Associate Professor, Urology, UCLA School of Medicine
Urology
Dr. Allan Pantuck, MD
|
|
Give Review
Doctor Allan Pantuck, MD is an expert in the field of Urology. He graduated from Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74/67 in Research/PrimaryCare. He has 1 awards "Fellow (FACS)". Dr. Allan Pantuck is a published doctor as well. He has 22 publications published. The latest was: Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. He accepts all Medicare patients.
Publications
- The High-Dose Aldesleukin "Select" Trial: A Trial to Prospectively Validate Predictive Models of Response Treatment in Patients with Metastatic Renal Cell Carcinoma.
- Re: Grant D. Stewart, Fiach C. O'Mahony, Alexander Laird, et al. Carbonic Anhydrase 9 Expression Increases with Vascular Endothelial Growth Factor-Targeted Therapy and...
- Clear cell Renal cell carcinoma: multiphasic MDCT enhancement can predict the loss of chromosome 8p.
- Poor prognosis and advanced clinicopathological features of clear cell Renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia...
- Prognostic Impact of Preoperative Neutrophil-to-Lymphocyte Ratio in Localized Nonclear Cell Renal Cell Carcinoma.
- A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate Cancer before radical prostatectomy.
- IGFBP-3 nuclear localization predicts human prostate Cancer recurrence.
- Clear Cell Renal Cell Carcinoma: Discrimination from Other Renal Cell Carcinoma Subtypes and Oncocytoma at Multiphasic Multidetector CT.
- Deletions of chromosomes 3p and 14q molecularly subclassify clear cell Renal cell carcinoma.
- Abiraterone in metastatic prostate Cancer without previous chemotherapy.
- Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell Renal cell carcinoma.
- Systemic therapy for metastatic Renal cell carcinoma: a review and update.
- Functional and oncological outcomes of partial nephrectomy of solitary Kidneys.
- Carbonic anhydrase IX in Bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
- Presence of tumor necrosis is not a significant predictor of survival in clear cell Renal cell carcinoma: higher prognostic accuracy of extent based rather than presen...
- Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience.
- Cytogenetic profile predicts prognosis of patients with clear cell Renal cell carcinoma.
- Molecular biology of Renal cortical tumors.
- Cancer-specific survival outcomes among patients treated during the cytokine era of kidney Cancer (1989-2005): a benchmark for emerging targeted Cancer therapies.
- Salvage-targeted kidney Cancer therapy in patients progressing on high-dose interleukin-2 immunotherapy: the UCLA experience.
- Genomic characterization of sarcomatoid transformation in clear cell Renal cell carcinoma.
Schools
UmdnjRobert Wood Johnson Medical School
UMDNJ R W Johnson Med School
Procedures Preformed
- Complete Nephrectomy With Robotic Assistance
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Kidney and Ureter Removal
- Kidney Stone Removal (Percutaneous Nephrostolithotomy, PCNL)
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Semen (Hematospermia)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
UMDNJ-Robert Wood Johnson Medical School -
Rutgers Robert Wood Johnson Medical School
Hospital
-
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Drug Facts
| NPI NUMBER | 1386663227 | |
| NPPES Provider LastName | PANTUCK | |
| NPPES Provider FirstName | ALLAN | |
| NPPES Provider ZIPCode | 900953075 | |
| NPPES Provider State | CA | |
| Specialty Description | Urology | |
| Total Claim Count | 347.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1386663227 |
| Last Name Of The Provider | PANTUCK |
| First Name Of The Provider | ALLAN |
| View All |
Similar Doctors
|
Dr. Inderbir S. Gill, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Scott Zeitlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raj Satkunasivam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Viet Q. Tran, MD |
|
|
Dr. Hooman Djaladat, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Matt S. Ashley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melanie C. Wuerstle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan Bergman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jesse D. Le, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madhur M. Merchant, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric T. Miller, MD |